- Original article
- Open access
- Published:
The role of mean platelet volume in predicting severity and prognosis of liver cirrhosis in Egyptian patients
The Egyptian Journal of Internal Medicine volume 31, pages 261–265 (2019)
En
Abstract
Background and aims
Liver cirrhosis is a major public health problem in Egypt due to widespread infection of hepatitis C virus. Mean platelet volume (MPV) is a noninvasive, inexpensive parameter of complete blood count. In this study we aimed at evaluating the association between MPV and clinical features, complications, and severity of cirrhosis in Egyptian patients.
Patients and methods
One hundred and fourteen patients with cirrhosis of various grades of severity and various presentations were enrolled in our study. The patients were evaluated to assess the association between MPV values and cirrhosis parameters, model for end-stage liver disease score, and fibrosis (FIB4) score.
Results
The study demonstrates the positive correlation between MPV values and international normalized ratio, serum bilirubin, lower serum albumin in cirrhotic patients. Also, the MPV values were significantly higher in patients with more severe liver disease according to the model for end-stage liver disease (r=+0.424, P=0.008) and FIB4 scores (r=+0.353, P=0.03).
Conclusion
MPV can be used as an important inexpensive biomarker in cirrhotic patients for the degree of severity and prognosis of the disease.
References
Giannini EG, Marenco S, Fazio V, Pieri G, Savarino V, Picciotto A. Peripheral blood cytopaenia limiting initiation of treatment in chronic hepatitis C patients otherwise eligible for antiviral therapy. Liver Int 2012; 32: 1113–1119.
Witters P, Freson K, Verslype C, Peerlinck K, Hoylaerts M, Nevens F et al. Blood platelet number and function in chronic liver disease and cirrhosis. Aliment Pharmacol Ther 2008; 27: 1017–1029.
Karagöz E, Tanoglu A. Prognostic role of mean platelet volume in patients with chronic hepatitis C. Clin Res Hepatol Gastroenterol 2014; 38: e113.
Cho SY, Yang JJ, You E, Kim BH, Shim J, Lee HJ et al. Mean platelet volume/platelet count ratio in hepatocellular carcinoma. Platelets 2013; 24: 375–377.
Han L, Han T, Nie C, Zhang Q, Cai J. Elevated mean platelet volume is associated with poor short-term outcomes in hepatitis B virus-related acute-on-chronic liver failure patients. Clin Res Hepatol Gastroenterol 2015; 39: 331–339.
Abdel-Razik A, Eldars W, Rizk E. Platelet indices and inflammatory markers as diagnostic predictors for ascitic fluid infection. Eur J Gastroenterol Hepatol 2014; 26: 1342–1347.
Vallet-Pichard A, Mallet V, Nalpas B, Verkarre V, Nalpas A, Dhalluin-Venier V et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology 2007; 46: 32–36.
Ceylan B, Mete B, Fincanci M, Aslan T, Akkoyunlu Y, Ozgunes N et al. A new model using platelet indices to predict liver fibrosis in patients with chronic hepatitis B infection. Wien Klin Wochenschr 2013; 125: 453–460.
Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: a link between thrombosis and inflammation. Curr Pharm Des 2011; 17: 47–58.
Purnak T, Olmez S, Torun S, Efe C, Sayilir A, Ozaslan E et al. Mean platelet volume is increased in chronic hepatitis C patients with advanced fibrosis. Clin Res Hepatol Gastroenterol 2013; 37: 41–46.
Giannini EG, Moscatelli A, Brunacci M, Zentilin P, Savarino V. Prognostic role of mean platelet volume in patients with cirrhosis. Dig Liver Dis 2016; 48: 409–413.
Köksal AŞ, Köklü S, İbiş M, Balci M, Ciçek B, Saşmaz N et al. Clinical features, serum interleukin-6, and interferon-γ levels of 34 turkish patients with hepatoportal sclerosis. Dig Dis Sci 2007; 52: 3493–3498.
Hessel G, Escanhoela CA, de Oliveira AD, De-Maria HK, Onishi E, Yamada RM et al. Hepatoportal sclerosis associated with portal vein thrombosis in children: report of 3 cases. Arq Gastroenterol 1997; 34: 121–125.
Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006; 43: 1317–1325.
Ekiz F, Yüksel O, Koçak E, Yılmaz B, Altınbaş A, Çoban S et al. Mean platelet volume as a fibrosis marker in patients with chronic hepatitis B. J Clin Lab Anal 2011; 25: 162–165.
Author information
Authors and Affiliations
Corresponding author
Additional information
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
Rights and permissions
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Mohamed, M.S., Bassiony, M.A.A. & Elsayed Mohamed, A.F. The role of mean platelet volume in predicting severity and prognosis of liver cirrhosis in Egyptian patients. Egypt J Intern Med 31, 261–265 (2019). https://doi.org/10.4103/ejim.ejim_111_18
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.4103/ejim.ejim_111_18